BMJ Open (Jun 2019)
Cost-effectiveness analysis of sofosbuvir plus ribavirin in patients with genotype 2 chronic hepatitis C: an analysis with real world outcomes from a multicentre cohort in Japan
Abstract
No abstracts available.
BMJ Open (Jun 2019)